JFLLIFE Stock Overview
JFL Life Sciences Limited engages in the manufacture and sale of pharmaceutical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
JFL Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹43.75 |
| 52 Week High | ₹56.00 |
| 52 Week Low | ₹36.05 |
| Beta | 0 |
| 1 Month Change | 1.74% |
| 3 Month Change | -3.42% |
| 1 Year Change | 0.11% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -34.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| JFLLIFE | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 7.0% | 1.8% | 1.6% |
| 1Y | 0.1% | 57.0% | 45.1% |
Return vs Industry: JFLLIFE underperformed the Indian Pharmaceuticals industry which returned 57% over the past year.
Return vs Market: JFLLIFE underperformed the Indian Market which returned 45.1% over the past year.
Price Volatility
| JFLLIFE volatility | |
|---|---|
| JFLLIFE Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: JFLLIFE has not had significant price volatility in the past 3 months.
Volatility Over Time: JFLLIFE's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Smiral Patel | www.jfllifesciences.com |
JFL Life Sciences Limited engages in the manufacture and sale of pharmaceutical products in India and internationally. It offers B-Lactam dry powder injections, and solid oral dosage form tablets and capsules; general solid oral dosage form tablets and capsules; and oral rehydration solutions. The company was incorporated in 2010 and is headquartered in Ahmedabad, India.
JFL Life Sciences Limited Fundamentals Summary
| JFLLIFE fundamental statistics | |
|---|---|
| Market cap | ₹481.18m |
| Earnings (TTM) | ₹31.20m |
| Revenue (TTM) | ₹442.90m |
15.4x
P/E Ratio1.1x
P/S RatioIs JFLLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JFLLIFE income statement (TTM) | |
|---|---|
| Revenue | ₹442.90m |
| Cost of Revenue | ₹360.80m |
| Gross Profit | ₹82.10m |
| Other Expenses | ₹50.90m |
| Earnings | ₹31.20m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.84 |
| Gross Margin | 18.54% |
| Net Profit Margin | 7.04% |
| Debt/Equity Ratio | 20.8% |
How did JFLLIFE perform over the long term?
See historical performance and comparison